FINANCIAL REPORTS
2022/2023
As a result of Bluefish Pharmaceuticals AB being a subsidiary consolidated by Färna Invest AB, Bluefish has, in accordance with current legislation, adapted the financial year to Färna Group in 2022. The financial year covers the period 1 May to 30 April. The financial year of the conversion year has been extended and covers the period from 1 January 2022 to 30 April 2023.
In consequence, from June 2022 interim reports are therefore prepared and made available only to shareholders who so request. The next report that will be prepared and provided to the shareholders is the annual report for the period January 1, 2022, to April 30, 2023.
2021
- Interim-report-Jan-Mar-2021
- Interim-report-Jan-June-2021
- Interim-report-Jan-Sept-2021
- Interim-report-Jan-Dec-2021
- Annual report 2021
- Sustainability report 2021
2020
- Interim-report-Jan-Mar-2020
- Interim-report-Jan-June-2020
- Interim-report-Jan-Sept-2020
- Interim-report-Jan-Dec-2020
- Annual report 2020
2019